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Abstract 
Summary: Objectives. To investigate the perceptual, physiological, acoustic and 
aerodynamic outcomes of patients with vocal nodules following intensive voice 
treatment compared to traditional voice treatment.  
Study Design. Pragmatic randomised clinical trial  
Methods. Fifty-three women diagnosed with bilateral vocal nodules participated in 
the study. Voice recordings, stroboscopic recordings, acoustic and aerodynamic 
assessments were made prior to voice treatment, after vocal hygiene education, and 
immediately postvoice treatment. All participants completed one session of vocal 
hygiene and eight sessions of direct voice therapy, however the delivery of the 
treatment between the two groups differed in treatment intensity.  
Results. Physiological improvements were observed after vocal hygiene alone, while 
physiological, perceptual, and acoustic parameters all improved to some degree in 
both treatment groups immediately posttreatment. There were no differences in the 
extent of change observed between the two groups at any time point following 
treatment. 
Conclusions. The investigation provided initial evidence that individuals with vocal 
nodules are able to recover voice function, vocal health and vocal communication 
through intensive voice treatment. The results suggest comparable positive perceptual, 
  
physiological and acoustic outcomes from intensive voice therapy compared with 
traditional voice therapy. Further investigation is required to determine the long-term 
effects of intensive treatment. 




Vocal nodules are benign lesions of the vocal folds caused by repetitive mucosal 
injury leading to histological changes and concomitant voice mutation.1 Their 
presence causes changes to the vibratory pattern of the vocal cords due to an increase in 
vocal fold mass and can impact vocal fold adduction both anteriorly and posteriorly to 
the nodule.2 The resultant dysphonia is perceived as breathy with various degrees of 
turbulent noise, strained vocal quality, roughness, instability and vocal fry/creak, with a 
tendency towards a low pitch.2-4 
 Individuals with vocal nodules constitute a large part of the client population at 
voice clinics.5 The voice disturbances can cause personal problems and societal losses, 
as individuals with vocal nodules in professions with high voice demands are forced 
to take long periods of sick leave and sometimes may have to change careers.5,6 As a 
consequence, extensive research has been conducted on the efficacy of treatment for 
vocal nodules, with voice therapy recommended as first-line treatment.5,7-14  
 Behavioural intervention has been shown to have a positive impact on vocal 
nodules, with number of studies confirming a marked reduction or complete 
elimination of the nodules posttreatment.5,7,8,11,15-20 Evidence also confirms that voice 
quality significantly improves postvoice therapy.7,8,10,19,21 Positive outcomes have also 
been reported across a range of acoustic measures, with jitter, shimmer, 
  
signal-to-noise ratio, fundamental frequency (F0), maximum phonation time (MPT) 
and mean airflow rate positively correlated with voice improvement following 
treatment for vocal nodules.7,8,12,19 
 Although the majority of research conducted to date has demonstrated the 
positive effects voice therapy has on vocal nodules, there is considerable variation in 
the duration and intensity of the therapy provided. In fact, no report has provided 
evidence or clear guidelines as to the optimal intensity or duration of voice therapy for 
clients with this vocal pathology.5,8,11,14,16,19 Studies have reported voice treatment 
protocols which include 2 to 16 sessions,12 once per week for 12 weeks,18 twice 
weekly for 2 to 4 months,16 and 4 to 6 months in duration.8 
 For voice therapy to be effective, both motor learning and cognitive processes 
for maintenance and transfer of the new vocal behaviour should be considered. 
According to Schmidt and Lee,22 motor learning is a set of processes associated with 
practice or experience leading to relatively permanent changes in movement. Practice 
conditions include the following: amount and distribution of practice, the variability 
of practice, the scheduling of practice with several different tasks, and part versus 
whole practice. These independent variables affect the learning of motor skills. One 
variable which may have an effect on learning and has not been widely investigated, 
is the distribution of practice. Practice distribution refers to how a given amount of 
  
practice is distributed over time,23 and may be described as massed or spaced practice. 
In massed practice, all the practice periods occur very closely together with little or no 
rest time in between sessions. In a spaced practice schedule, the time interval between 
the practice periods is increased significantly.24 
 Few empirical data exist on the effects of practice distribution in speech motor 
learning. The strongest evidence exists for massed practice. For example, the Lee 
Silverman Voice Treatment (LSVT®), which incorporates principles of multiple 
repetition, high intensity, and high frequency of practice (four treatment sessions per 
week for four weeks), has been shown to result in long-term vocal improvements in 
the speech and voice of people with Parkinson’s disease.25,26 It is postulated that this 
treatment facilitates intensive motor relearning, maximises motor output and effort, 
increases drive and goal directed activity, and enhances sensory awareness to promote 
internal cueing, self monitoring and upscaling of motor output.27 
 The benefits of massed, intensive practice were also noted in the treatment of 
functional dysphonia.28,29 In a concept article, the authors provided a framework and 
indications for delivery of intensive short-term voice therapy, referred to as “boot 
camp”.28 This involved concentrated practice, using a variety of voice therapy 
techniques, delivered in a concentrated time frame (1 to 4 days with 4 to 7 hours of 
therapy per day). This type of therapy was reported to be tailored to the nature of the 
  
voice disturbance and individual specific needs, thereby maximizing the individual’s 
ability to learn and carryover targets to non-clinical environments. The authors stated 
that this approach can be successfully used with various types of dysphonia, 
especially those who have not been successful with traditional voice treatment 
approach, and with clients living at geographical distances sufficiently far from voice 
centres.28 However, clinical trials have not yet been conducted on the “boot camp” 
treatment approach. Patel et al.28 speculated that the nature of the high-intensity 
training may better mimic cognitive, motor, and physiological requirements of 
activities of daily living than traditional therapy.  
 Potential advantages of intensive treatment are that: rigorous practice (overload) 
is possible; simultaneous interventions can be conducted for multiple components 
involved in voice production; and opportunities for specificity, individuality, and 
facilitating transfer of learned skills which may influence patient compliance are 
readily available.29 Thus in translating this evidence to the management of vocal 
nodules, it is possible that intensive voice therapy may be more beneficial than 
traditional treatment protocols, and offer greater speed and efficiency in achieving 
improvement in vocal function. To date no study has explored the relative efficacy of 
intensive treatment specifically for individuals with vocal nodules. Therefore, the aim 
of the present study was to investigate the perceptual, physiological, acoustic, and 
  
aerodynamic outcomes of patients with vocal nodules following intensive voice 
treatment when compared to traditional voice therapy. It is hypothesised that greater 
improvement in perceptual, physiological, and acoustic parameters will occur 




Ethics approval for the study was obtained from the Taipei Veterans General Hospital 
and The University of Queensland Medical Research Ethics Committee.  
 
Participants 
Fifty-three women (mean age 37.5 years, range 20-54) referred from the outpatient 
clinic at the Department of Otorhinolaryngology Department, Taipei Veterans General 
Hospital, Taiwan, and diagnosed with bilateral vocal nodules were included in the 
study. The diagnoses of vocal nodules were made by one of five otolaryngologists 
from videostroboscopic examination, while the severity of dysphonia was determined 
by one speech-language pathologist (SLP) experienced in the area of voice and blind 
to the study purpose. Overall severity was rated using the “Grade” scale from the 
GRABS (Grade, Roughness, Breathiness, 
  
Asthenia, Strain) scale30 (where 0 = normal, 1 = mild, 1.5 = mild-to-moderate, 2 = 
moderate, 2.5 = moderate-to-severe, and 3 = severe) and was based on evaluation of a 
sample of reading (a standard Mandarin passage). Participants were included in this 
study if they: 1) were aged between 18 years and 55 years; 2) had normal articulation, 
resonance, and language ability; 3) had normal hearing as determined by a screening 
test at 20 dB HL at 3 frequencies 500, 1000, 2000 Hz; 4) had no previous professional 
singing or speaking training; and 5) had no previous voice therapy or laryngeal 
surgical treatment. Exclusion criteria included: 1) use of prescription medication 
which may cause changes in laryngeal function, mucosa or muscle activity (list 
provided by National Center for Voice and Speech [NCVS]32); 2) current psychiatric 
or neurologic conditions; or 3) a history of allergies, lung disease, or other 
concomitant vocal pathology (eg, vocal polyp and vocal cyst). 
 Participants were matched in pairs according to their age, occupation, and 
severity of dysphonia. The duration of dysphonia prior to treatment was not taken into 
consideration. The participants occupations were categorised into non-professional 
voice users (eg, factory worker, students, catering, clerical worker, home carers, and 
unemployed) versus professional voice users (eg, teachers, health professional, and 
sales personnel). All participants were diagnosed with bilateral broad-based nodules 
before treatment. Participants in each pair were then assigned to either of two 
  
treatment groups according to their availability: intensive voice therapy (IVT) or 
traditional voice therapy (TVT) groups. Thirty-one participants were recruited to the 
intensive voice program. Seven withdrew or failed to complete the full program (for 
health, work or personal reasons), leaving 24 participants who completed the 
intensive voice therapy program. A total of 37 participants were recruited to the 
traditional voice therapy program group. Eight withdrew or failed to complete the 
entire program, leaving 29 participants who completed the entire traditional voice 
therapy program. Demographic information of the 53 participants who completed 
both programs is detailed in Table 1.  
 Comparisons of baseline characteristics between the two groups were conducted 
using independent t-tests for parametric data (age, acoustic, and aerodynamic 
measurements) and chi-square tests and Mann-Whitney U tests for non-parametric 
data (occupation, severity of dysphonia, existence of vocal fold oedema and vocal 
nodule location). There were no statistical differences between the groups with 
regards to their age (t= -0.165, p = 0.871), severity of dysphonia (Z = -1.861, p = 
0.063), or occupation (χ2 = 0.053, p = 0.817) at presentation. With respect to 
pretreatment acoustic and aerodynamic measurements no significant differences were 
found between groups all on all parameters. There were no significant differences 
between the groups with respect to vocal nodule location (Z = -0.195, p = 0.845) or 
  
surrounding oedema of the vocal folds (χ2 = 2.511, p = 0.113). In the TVT group, 27 
(93%) had nodules located on the front 1/3 of the vocal folds while 2 (7%) were 
located mid-vocal folds. In the IVT group, 22 (92%) had nodules located on the front 
1/3 of the vocal folds with 2 (8%) participants having nodules located mid-vocal fold. 
All of the participants from TVT group had surrounding oedema prior to treatment as 
did 92% (n = 22) of the IVT group.  
 
Procedure 
Participants completed assessments at three time intervals relative to therapy: 1) 
before the initial vocal hygiene session, 2) three weeks after the vocal hygiene session 
and immediately prior to IVT/TVT voice therapy, and 3) immediately following IVT 
or TVT. All assessments were performed by a SLP and otolaryngologists experienced 
in voice disorders who were independent to the study and blinded to group allocation. 
 
Auditory perceptual ratings 
At each assessment interval, the participants were asked to read a Mandarin passage 
consisting of five sentences. Samples were recorded with a Shure SM48-LC 
microphone and stored in the Computerised Speech Laboratory system (CSL; model 
4500, Kay Elemetrics Co.) at a 4.41 KHz sampling rate in a sound-treated room. The 
  
desktop microphone was positioned in front of each participant’s mouth at a 
mouth-to-microphone distance of 15 cm.  
 Perceptual analysis was conducted by one SLP with 15 years experience 
assessing voice disorders. Voice quality was assessed using the GRBAS scale, 30 
which consists of five parameters: grade (G), roughness (R), breathiness (B), 
asthenicity (A) and strain (S). Ratings of the GRBAS parameters were conducted as 
paired comparisons, using the Comparison Mean Opinion Score (CMOS) process.33 
This process allows the rater to detect even subtle changes in a patient’s voice or 
speech characteristic by allowing them to listen to, and compare an individual’s 
speech sample in pairs (eg, pre- and posttherapy), and rate the second sample relative 
to the characteristics of the first sample. A clinician independent of the rating process 
created pairs of recorded speech samples for each participant relating to the 
assessment time points (ie, prevocal hygiene and postvocal hygiene; prevocal hygiene 
and postvoice therapy; postvocal hygiene and postvoice therapy). The order of the 
two samples in each pair was randomized to reduce any potential expectation bias. 
After listening to each pair of the entire speech sample, the clinician then rated sample 
2 in relation to sample 1 on a scale of -3 to +3, in which 0 indicates the samples are 
equal. If the value is negative, it indicates that sample 2 is worse than sample 1 (-1 
mildly worse; -2 worse and -3 severely worse). However, if the value is positive, it 
  
indicates that sample 2 is better than sample 1 (+1 mildly better; +2 better and +3 
much better). The SLP was able to listen and compare the speech samples as often as 
they wished. Once the paired samples were rated, the principle investigator revealed 
the order of the two samples and transposed the scores to ensure data accurately 
reflected perceptual differences relative to the time of speech sample recording such 
that any positive score indicated an improvement, and negative values, a decline in 
function.  
 Inter-rater reliability was explored by having a SLP with eight years experience 
assessing voice disorders rate a random set of 33 samples (20% of the total voice 
samples). Reliability was calculated using intraclass correlation coefficient (ICC) as 
well as direct calculation of the Percent Exact Agreement (PEA) and the Percentage 
of Close Agreement (PCA - where raters differed by no more than 1 scale point). The 
calculated results were derived from mean values of all perceptual parameters. Results 
of the ICC (0.64) revealed substantial agreement33 while the PEA was 74% and the 
PCA was 93%. For intra-rater reliability the primary rater re-rated 20% of the sample 
a second time, at no sooner than four weeks following initial assessment. The ICC of 
0.85 indicated almost perfect agreement,33 with the PEA 71% and PCA was 99%.  
 
Videostroboscopic evaluation – physiological ratings 
  
The videostroboscopic recordings were made during the sustained phonation of the 
vowel /i/ produced at a comfortable loudness and pitch. The stroboscopic assessments 
were conducted by any one of five otolaryngologists at any assessment point. The 
recorded videostroboscopic samples were then subsequently rated by one primary 
otolaryngologist with seven years experience assessing voice disorders.  
 The videostroboscopic ratings were performed in two stages. The first stage rated: 
the symmetry of vocal fold abduction and vibration; the regularity and amplitude of 
the vocal fold movement, vocal fold edge smoothness, mucosal wave characteristics 
and glottal closure using a 4 point scale (0 = normal; 1 = mild; 2 = moderate; 3 = 
severe); Additional parameters, nodule location (very front, front, mid, back of the 
vocal fold membranous portion), nodule shape (narrow-based, broad-based); and 
surrounding oedema (yes/no) were also rated. The 159 samples (53 participants by 
three samples per participant) were randomized prior to presentation to the 
otolaryngologists for rating in order to reduce any potential bias. The 
otolaryngologists were able to review each videostroboscopic sample for as long as 
they wished. The ratings were completed from visual impression only and the videos 
were presented without sound.  
 The second stage of the videostroboscopic rating process, was to use the paired 
sample comparison process (as described previously) to rate paired samples (prevocal 
  
hygiene and postvocal hygiene; prevocal hygiene and postvoice therapy; postvocal 
hygiene and postvoice therapy) using a questionnaire adapted from Holmberg, 
Hillman, Hammarberg, Sodersten, and Doyle.8 Ratings of sample two compared to 
sample one were rated for changes in: (1) nodule size (difference between the two 
recordings, -1 larger; 1 smaller; 0 no difference), and; (2) surrounding oedema 
(difference between the two recordings: -1 larger; 1 smaller; 0 no difference). Once 
the samples were rated, the principle investigator revealed the order of the samples 
and transposed the scores to ensure data accurately reflected differences relative to the 
time of videostroboscopic sample recording (prevocal hygiene, postvocal hygiene and 
postvoice therapy). 
 Inter rater reliability of the primary rater was determined using a second 
otolaryngologist with nine years experience assessing voice disorders who rated a 
random set of 33 samples (20% of the total videostroscopic samples). The calculated 
results were mean values of all physiological parameters. The ICC revealed almost 
perfect agreement for inter-rater reliability (0.88), while the PEA was 74% and PCA 
was 99.6% respectively. Intra-rater reliability (based on 20% of the sample rated no 
sooner than four weeks following initial assessment) was also almost perfect (0.91), 




Aerodynamic assessment included measures of maximum phonation time (MPT), 
mean airflow rate (MFR) and subglottic pressure. MPT was measured with a 
stopwatch while participants were asked to produce the sustained vowel /a/ for as long 
as possible at a comfortable loudness and pitch level on a single breath, three times. 
The MFR and subglottic pressure were obtained and analysed using the Aerophone II 
(Model 6800, Kay Elemetrics Co., Lincoln Park, NJ). Each participant was asked to 
produce a sustained vowel /a/ for as long as possible at a comfortable intensity and 
pitch level with a face mask, sealed over the nose and mouth connected to a 
pneumotachograph- based flow system, three times. The subglottal pressure was 
measured indirectly using an intraoral pressure probe positioned behind the lips and 
resting on the tongue. The participants were asked to repeat /ipipip/ with the face 
mask and probe in place at a rate of 1.5 syllables/second, three times. Results for each 




All acoustic recordings were conducted in a sound-proof room. The participants were 
asked to produce a sustained vowel /a/ on one breath at a comfortable pitch and 
  
loudness level, three times. Vowel productions were recorded via the desktop 
microphone of the Computerized Speech Lab (CSL) (Model 5105, Kay Elemetrics 
Co.). The microphone was positioned in front of the participant with a 
mouth-to-microphone distance of 15 cm. Each participant’s production of sustained 
/a/ was analysed using the Multi-Dimensional Voice Program (MDVP) software (Kay 
Elemetrics, Lincoln Park, NJ) in the CSL. The middle 3-second segment from each of 
the sustained vowels was selected for acoustic analysis. Detailed voice stability 
measures included: vocal fundamental frequency (Fo) (Hz), mean percentage vocal 
jitter and shimmer, and noise-to-harmonics ratio (NHR) (dB). Results across the three 
vowel phonations were averaged to produce a single value for each measure. In 
addition, participants’ vocal intensity (VI) (dB) for the three prolonged vowels /a/ and 
additional conversational speech samples were simultaneously measured using Sound 
Level Meter (320 series, Center Technology Corp., Taiwan) which was also 
positioned in front of the participant with a mouth-to-microphone distance of 15 cm. 
Vocal intensity recorded for the prolonged vowel phonations and conversational 
speech samples were averaged to produce a single value for each measure. 
 
Therapy program 
The therapy program for each treatment group consisted of both indirect and direct 
  
therapy treatment strategies. Both groups began voice therapy with indirect treatment 
strategies in which all participants were asked to follow general voice hygiene 
measures (adapted from Weinrich,34 Verdolini Abbott,35 and NCVS36). Participants in 
each group were then scheduled to return for eight-sessions of direct voice therapy 
three weeks later. The therapy program which was followed over the eight sessions in 
both groups was identical. Only the intensity of its delivery varied between the groups. 
The TVT (control) group received one session of direct therapy per week for eight 
weeks (8 sessions of therapy). The IVT group received eight sessions delivered within 
a three week period (ie, three times per week in the first two weeks and two times in 
the third week). All sessions, regardless of group, were 45 minutes in duration.  
 The voice therapy was provided by the principle investigator who was not 
involved in assessment of the participants. The principle investigator was trained and 
certified to provide the therapy program which was adapted from the Lessac-Madsen 
Resonant Voice Therapy (LMRVT) developed by Verdolini Abbott.35 Components of 
the Vocal Function Exercises (VFE) program developed by Stemple were also 
incorporated in the speech tasks.37 LMRVT focuses on the production of resonant 
voice which has been defined as a vocal quality that projects well, is easy to produce; 
involves a sensation of vibration in the mask of the face; and is characterised by 
ample harmonic content.38 It is generally produced with relatively complete 
  
anteroposterior vocal fold closure during phonation.14 The focus of this therapy is: (1) 
the production of concentrated vibratory sensations on the anterior palate during 
phonation, using an “inverted megaphone” facial posture, and (2) upper body 
relaxation, using manual manipulations to reverse any obvious head, neck, or shoulder 
tensions and to obtain good head and neck alignment.14 VFE represents a holistic 
approach to voice treatment designed to rebalance the three subsystems of voice, 
respiration, phonation, and resonance.39 These exercises are designed to build strength 
and endurance in the laryngeal muscles and in doing so improve range and control for 
voice production.2,38 The exercises also facilitate better control over airway valving 
and in so doing reduce hyperfunctional laryngeal behaviours.2  
 Therapy began with shoulder, neck, and facial muscle relaxation followed by 
basic training gestures as described by Verdolini Abbott35 and Roy et al.40 Direct 
facilitation of voice through stretch (ascending pitch glide) and contraction exercises 
(descending pitch glide) on the word “knoll”, “whoop”, or “boom” with an extreme 
forward focus was completed. Therapy tasks extended to sounds in isolation, 
conversation, and real-life applications outside of the therapy room, based on the 
clinician’s impression that earlier levels in the therapy hierarchy had been 
successfully mastered. All participants were asked to practice voice techniques 
worked on in the therapy session at home, in two 15-minutes sessions per day on 
  
non-therapy days, and once per day on therapy days. The techniques were provided in 
worksheets in the form of a daily checklist for participants to take home. 
 
Statistical Analysis 
The Statistical Package for the Social Sciences (SPSS) version 20 (SPSS, Inc., 
Chicago, IL) was used for all statistical analysis and level of significance was set at P 
< 0.05. Analysis involved both within group and between group analyses. For within 
group analysis, the paired comparison ratings (between baseline and postvocal 
hygiene, baseline and posttreatment, and postvocal hygiene to posttreatment) 
conducted for the perceptual parameters of grade; roughness; breathiness; asthenia; 
strain and also for the physiological parameters of nodule size and oedema were 
analysed using a series of one sample t tests (2-tailed) where 0 was taken to indicate 
no difference between the sample pairs. 
 For the physiological parameters of the symmetry of vocal fold abduction and 
vibration; the regularity and amplitude of the vocal fold movement; vocal fold edge 
smoothness; mucosal wave; and glottal closure were analysed using Friedman’s tests 
to explore extent of within group change in each treatment group (IVT and TVT) 
across the three time points (baseline, postvocal hygiene, and postvoice treatment). 
Any significant result was examined further using posthoc Wilcoxon signed rank 
  
tests.  
 Prior to conducting the between group analysis, data from the physiological 
ratings (symmetry of vocal fold abduction and vibration, the regularity and amplitude 
of the vocal fold movement, vocal fold edge smoothness, mucosal wave and glottal 
closure) were converted to change scores, calculated as the difference between the 
baseline and postvocal hygiene ratings, between baseline and posttreatment ratings, 
and between postvocal hygiene and posttreatment for each participant in each group. 
Mann-Whitney U tests were then used to determine any differences in the extent of 
change across the physiological parameters at baseline to postvocal hygiene, baseline 
to posttreatment and postvocal hygiene to posttreatment between the IVT and TVT 
groups.  
 To explore between group differences for the perceptual and physiological data 
from the paired comparisons ratings, the proportions of participants identified as 
either better, worse or no different at postvocal hygiene and posttreatment were 
calculated then compared between the groups, using chi-square tests. 
 With regards to acoustic and aerodynamic measures, to identify differences 
between the two treatment groups (IVT and TVT) across time (pre-, postvocal 
hygiene, and after voice treatment) as well as any interaction occurring between 
treatment group and time, two-factor repeated measures analyses of variances 
  
(ANOVAs) were used. Where a significant (P < 0.05) effect for time was found, 
posthoc procedures were performed to determine where the significant difference 
occurred (ie, between pre- and postvocal hygiene, postvocal hygiene and 
posttreatment, or pre- and posttreatment) within each group.  
 
Results 
Perceptual ratings – paired comparisons 
Within group analysis. T tests revealed that between baseline and postvocal hygiene, 
there were no significant changes across any of the perceptual parameters except for 
strain, which improved significantly (P < 0.05) in the TVT group only (Table 2). The 
comparison between baseline and posttreatment showed that both the TVT and IVT 
groups were found to have significantly improved ratings of overall voice quality, 
roughness, breathiness, weakness of voice, and strain. Comparison between postvocal 
hygiene and posttreatment also demonstrated significantly improved ratings of overall 
voice quality, roughness, and strain of voice in both groups, with IVT group showing 
additional significant improvement in breathiness and weakness of voice (Table 2).  
Between group analysis. Descriptive analysis and chi-Square tests showed that there 
were no differences in the proportions of patients making positive change between the 
groups at either baseline to postvocal hygiene, baseline to postvoice treatment or post- 
  
vocal hygiene to postvoice treatment for all perceptual parameters (Table 3). 
 
Videostroboscopic ratings – physiological parameters 
Within group. Results of the physiological ratings over time for TVT and IVT groups 
are shown in Table 4. Friedman tests revealed a significant (P < 0.05) difference 
across the three time points for the ratings of mucosal wave, vocal fold edge 
smoothness, regularity of vocal fold movement, and glottal closure in both the IVT 
and TVT groups. There were no significant differences observed for symmetry of 
vocal fold abduction or amplitude of vocal fold movement over time in either group 
(Table 4). 
 Posthoc Wilcoxon signed rank tests revealed statistically significant 
improvements from baseline to postvocal hygiene for both the TVT and IVT groups 
for ratings of mucosal wave (TVT: Z = -2.738, P = 0.006; IVT: Z = -3.441, P = 0.001), 
vocal fold edge smoothness (TVT: Z = -3.317, P = 0.001; IVT: Z = -2.887, P = 0.004) 
and glottal closure (TVT: Z = -2.500, P = 0.012; IVT: Z = -1.968, P = 0.049). No 
significant differences were found between baseline and postvocal hygiene for 
regularity of vocal folds (TVT: Z = -0.707, P = 0.480; IVT: Z = -1.667, P = 0.096) for 
either groups.  
 Comparisons between postvocal hygiene to posttreatment revealed further 
  
significant (P < 0.05) improvements in mucosal wave (Z = -3.625, P < 0.001), vocal 
fold edge smoothness (Z = -3.464, P = 0.001), regularity of vocal movement (Z = 
-2.530, P = 0.011) and glottal closure (Z = -3.500, p < 0.001) for participants in TVT 
group. In the IVT group only, a significant improvement in mucosal wave (Z = -3.477, 
P = 0.001) was found between postvocal hygiene and posttreatment.  
 Between baseline and immediately postvoice therapy significant (P < 0.05)  
improvements were observed in mucosal wave (TVT: Z = -4.567, P < 0.001; IVT: Z = 
-4.110, P < 0.001), vocal fold edge smoothness (TVT: Z = -4.347, P < 0.001; IVT: Z 
= -3.300, P = 0.001), regularity of vocal fold movement (TVT: Z = -2.517, P = 0.012; 
IVT: Z = -2.496, P = 0.013) and glottal closure (TVT: Z = -4.181, P < 0.001; IVT: Z = 
-2.982, P = 0.003) in both the TVT and IVT groups.  
Between group analysis. Mann-Whitney U tests revealed no significant differences in 
the extent of change between the groups at either baseline to postvocal hygiene, 
postvocal hygiene to pos treatment, or baseline to posttreatment for all parameters 
(Table 5). 
 
Videostroboscopic ratings – comparison of pairs 
Within group analysis. One sample t tests revealed that both groups demonstrated 
significantly improved ratings of vocal nodule size (TVT: t = 2.3, df = 26, P = 0.026, 
  
mean diff = 0.333; IVT: t = 3.7, df = 23, p = 0.001, mean diff = 0.500) and vocal fold 
oedema (TVT: t = 2.6, df = 26, P = 0.015, mean diff = 0.370; IVT: t = 4.1, df = 23, P 
< 0.001, mean diff = 0.500) following vocal hygiene. Comparison between postvocal 
hygiene and posttreatment revealed significantly improved ratings of vocal nodule 
size (TVT: t = 3.808, df = 27, P = 0.001, mean diff = 0.536; IVT: t = 2.865, df = 22, P 
< 0.001, mean diff = 0.435) and vocal fold oedema (TVT: t = 4.688, df = 27, P < 
0.001, mean diff = 0.607; IVT: t = 4.447, df = 22, P < 0.001, mean diff = 0.609). 
From baseline to postvocal therapy both groups demonstrated significantly improved 
ratings for vocal nodule size (TVT: t = 4.03, df = 28, P = 0.001, mean diff = 0.552; 
IVT: t = 15.199, df = 22, P < 0.001, mean diff = 0.913) and vocal fold oedema (TVT: 
t = 4.04, df = 28, P < 0.001, mean diff = 0.586; IVT: t = 10.199, df = 22, P < 0.001, 
mean diff = 0.826).  
Between group analysis. Descriptive analysis and chi-Square tests showed there were 
no significant differences between the groups at either baseline to postvocal hygiene, 
baseline to postvoice treatment or postvocal hygiene to postvoice treatment for all 
physiological paired comparisons with respect to the proportion of participants who 




A series of two-factor ANOVAs (group x time) conducted for each aerodynamic 
parameter revealed no significant interactions between group and time for any 
parameters (Table 7). There was also no main effect for time for any aerodynamic 
parameter. Furthermore, the between group effect was not significant for any 
aerodynamic parameters, suggesting no difference in the effectiveness of the two 
approaches regarding aerodynamic measures (Table 7).  
 
Acoustic measures 
Two-factor ANOVAs conducted for each acoustic parameter showed no significant 
interaction between group and time (Table 8). There was however a significant main 
effect for time for F0, jitter, shimmer, NHR and VI for prolonged /a/, with both groups 
showing an increase in values across the three time periods for F0 and VI of prolonged 
/a/ and a reduction in values for jitter, NHR and shimmer. There was no main effect 
observed for VI in conversation. In addition, the between group effect was not 
significant across all acoustic parameters, suggesting no difference in the effects of 
the two interventions on acoustic measures (see Table 8).  
 Posthoc tests performed on the acoustic parameters demonstrated a significant 
main effect for time. Analysis revealed no significant differences between pre- and 
postvocal hygiene across all acoustic parameters for both treatment groups, except for 
  
VI for prolonged /a/ (P = 0.019) in IVT group. However, significant increases in mean 
F0 were found for participants in both the IVT and TVT groups between baseline and 
immediately postvoice therapy. Both groups also experienced significant reductions in 
jitter (P < 0.001 and P = 0.012), and shimmer (P = 0.001 and P = 0.03) following 
treatment. Although there was a significant main effect for time for NHR, no 
significant differences were found in the posthoc analysis between time points in both 
groups, though a trend (P = 0.099 and P = 0.381, respectively) was observed for a 
reduction in NHR between baseline and posttreatment for TVT and IVT groups. 
Results of VI for prolonged vowel /a/revealed a significant increase immediately 
posttreatment in TVT group (P = 0.005) but not in IVT group (P = 0.069). 
 
Discussion 
Extensive studies have been conducted to investigate the benefits of voice therapy in 
the management of vocal nodules, however there is large variation in the duration and 
intensity of the therapy reported. This study examined perceptual, physiological, 
acoustic, and aerodynamic outcomes following two treatment intensity protocols for 
individuals with vocal nodules. The results of the current investigation provide 
support for comparable positive perceptual, physiological and acoustic effects from 
intensive voice therapy delivered over a shorter period of time (three weeks), 
  
compared with the traditional model of service delivery provided over eight weeks. 
Although both treatments modalities contributed to significant improvements 
posttreatment across most variables, the efficiency of intensive practice may be better 
suited to some patients. These findings support the benefits of massed practise as 
reported by other investigations.25,26,28 
 In the current study, no significant differences were noted postvocal hygiene 
perceptually, acoustically or aerodynamically in either group, except for a perception 
of reduced strain in the TVT group. In contrast, physiological assessment showed 
significant positive changes to mucosal wave, vocal fold edge smoothness, and glottal 
closure nodule size and surrounding oedema following the vocal hygiene program in 
both groups. This discrepancy in findings was also observed by Verdolini-Marston, 
Sandage and Titze41 who found significant improvement in laryngeal appearance 
following vocal hygiene (ie, hydration), however auditory-perceptual ratings fell short 
of statistical significance. A possible explanation for the lack of change in perceptual, 
acoustic and aerodynamic parameters postvocal hygiene could be that the subtle 
changes identified under videostroboscopic examination were not yet sufficient to 
result in other changes.  
 Although the intensive treatment protocol used in the current study may be 
considered to increase or exacerbate vocal loading for participants with vocal nodules, 
  
the significant improvements in perceptual and physiological parameters identified in 
participants postintensive treatment were comparable to the results yielded 
posttraditional treatment. Therefore, the results suggest that an intensive treatment 
schedule did not result in an increase in vocal loading with subsequent exacerbation 
of vocal pathology in this cohort. 
 Previous case study reports have documented positive changes in vocal fold 
morphology and function following vocal hygiene counselling alone.18 A specific 
vocal hygiene target, hydration, has been shown to have significant benefit on the 
laryngeal appearance on a group of participants with vocal nodules and polyps.41 The 
current findings also suggest that vocal hygiene education remains an important part 
of voice therapy as the issues discussed in vocal hygiene session (eg, hydration, 
reduction in voice use, reduction in consumption of foods which may cause gastric 
reflux) may have been responsible for the development of vocal nodules in the first 
place. However several reviews of vocal hygiene training have concluded that 
although it is beneficial to include vocal hygiene program, it should be considered 
only as a component of a comprehensive vocal rehabilitation program.42,43 Indeed 
recent studies have revealed that vocal hygiene education alone is ineffective for 
treating individuals with existing voice problems and that direct voice therapy is 
required to optimise treatment benefits.40,44-46 The current data would also support this 
  
opinion.  
 Previous investigators have reported that voice therapy is effective in restoring 
normal voice and improving voice quality in individuals with vocal nodules.7,8,10,19-21 
Specifically, it has been reported that breathiness and pressed quality of voice is 
significantly reduced posttherapy.8 Our study also yielded a similar result, in that 
participants from both TVT and IVT groups had significantly less rough, breathy, 
weak, and strained voices, and overall had a better voice quality immediately 
posttherapy when compared with baseline. As implied by Holmberg et al8 the 
decreased breathiness may reflect a reduction in nodule size, thus making more 
complete glottal closure possible. This is consistent with our physiological findings in 
that our participants had significantly reduced nodule size and glottal closure 
posttherapy.  
 The reduction in strained voice identified posttherapy in both groups, may have 
indicated decreased muscle tension, and improved speech respiratory behaviour with 
better management of air supply and a more efficient relationship between subglottal 
pressure and glottal function.8 The decrease in strained voice may also be reflected 
through the improved regularity of vocal fold movement and mucosal wave. A 
combination of the improvement of all voice qualities can be seen as an indicator of 
the efficacy of the voice therapy delivered in both groups.  
  
 
Several researchers have found regularity of vocal fold vibration, quality of mucosal 
wave and vocal fold closure to have improved with voice training; and elimination or 
marked reductions in nodules and surrounding oedema to have dissipated postvoice 
therapy.5,7,8,15-18,20 These findings were also demonstrated in the current study. When 
comparing baseline to immediately postvoice therapy, both the IVT and TVT groups 
demonstrated significant improvements in mucosal wave, vocal fold smoothness, 
regularity of vocal fold movement and glottal closure. In addition, there was 
significant reduction in nodules and surrounding oedema posttreatment for both 
groups. The improvement in mucosal wave, vocal fold smoothness, regularity of 
vocal fold movement and glottal closure may reflect an increase in effective mass of 
the vocal fold and a reduction in the size of the vocal nodules. 
 Although significant improvements were noted by the end of treatment, for the 
majority of the participants, their vocal nodules had not completely resolved, as has 
been observed by other researchers.5,8 It is postulated that although the trauma to the 
vocal folds may have decreased after therapy, the impact on the vocal fold physiology 
might not have been significant enough to allow complete amelioration of the nodular 
lesions.5,8 It is also suspected that those with larger nodules may require a longer care 
period.12 Direct treatment periods of three weeks and eight weeks may be insufficient 
  
for vocal nodules to completely resolve. Therefore, further long-term observations 
should be conducted to determine whether or not the resolution of vocal nodules 
persists. 
 The results of the acoustic analyses revealed there were significant increases in 
F0, and decreases in jitter, and shimmer, immediately after voice treatment for both 
groups which is consistent with previous research findings.20,47,48 The increase in F0 
may be due to a reduction in size of the vocal nodules and a decrease in surrounding 
oedema resulting in a decrease in the mass loading effects on the vibratory 
characteristics of the vocal folds.2,8,49 It was also noted there was a significant increase 
in vocal intensity for TVT group but not the IVT group. This increased vocal intensity 
may be attributed to the extended time provided for the TVT group to familiarise 
themselves with the use of vocal projection, which is a treatment component of 
LMRVT. As a result, participants developed a louder voice. The overall acoustic 
improvements found in both groups reflected increases in effective mass of the vocal 
fold, reduction in the vocal noise, and possibly diminishing vocal nodule size.8,50 This 
was confirmed by our physiological findings which showed significant improvement 
in mucosal wave, vocal fold edge smoothness, regularity of vocal fold movement, 
glottal closure, and significant reduction in vocal nodule size and vocal fold oedema 
immediately posttreatment. In addition, the acoustic improvement also positively 
  
correlated with participants' perceptual ratings in which overall voice quality, 
roughness, breathiness, weakness, and strain of voice were significantly improved. 
These changes indicated that the intensive and traditional treatment dosages used in 
this study were effective in the management of vocal nodules. As no statistical 
differences were found between the treatment groups, it is further suggested that 
intensive intervention over a three week period is of sufficient duration to improve 
voice outcome for individuals with vocal nodules. 
 Similar to the aerodynamic findings yielded by Holmberg et al5 and Treole and 
Trudeau,51 the current study found no significant changes in aerodynamic parameters 
posttreatment. It may be that as the participants’ aerodynamic measures were already 
in the normal range before voice treatment, significant changes were unable to be 
detected immediately following therapy.52 It may also be the case that as the 
smoothness of the vocal fold edges in the majority of the participants was only mildly 
or moderately affected at baseline, this did not impact on aerodynamic function 
through the therapy period. 
 It is known that majority of the individuals with vocal nodules work in 
professions which are high in voice demand, therefore, it is essential that they return 
to workforce as soon as possible with an adequate voice. Therefore, intensive voice 
therapy may be a preferable service delivery model as these individuals would be able 
  
to return to work with an improved voice within a shorter period of time. The benefits 
of such an intensive voice treatment include: voice improvement in a short period of 
time, increased patient compliance and understanding of home practice, more time 
efficient for both clinician and client, decreased time between sessions, and increased 
ability to carryover learned strategies into everyday life. Individuals are able to 
accelerate learning regulated by increasing therapy rate, therapy phase duration, and 
variability of practice, and decreasing the rest phase duration.28 Intensive contact with 
the clinician allows individuals with vocal nodules to resolve any queries and be 
provided with clinician’s feedback regarding their use of voice in a shorter time frame. 
This process can assist patients to consolidate their awareness and facilitates 
generalisation of treatment effects to daily living.29 In contrast, prolonged voice 
therapy as noted by Spielman et al.26 extends the time commitment for both client and 
clinician, with no additional gains to be made. 
 The overall outcome of this current investigation showed that both treatment 
approaches were able to provide improvements to vocal fold condition and vocal 
function. As such the data demonstrated that participants were able to improve voice 
and vocal fold health in the short period of time needed for the intensive therapy 
approach and were able to carryover vocal strategies into everyday life. Thus, the 
intensive model may be more time efficient and beneficial for people who have busy 
  
work schedules as they have the need to go back to work as soon as possible with a 
satisfactory voice. 
 While the present study revealed the potential value of providing treatment to 
individuals with vocal nodules in an intensive approach, there are limitations to the 
study. The first issue is the use of a pragmatic randomized controlled trial (RCT) 
design, over the more conventional RCT method. The pragmatic allocation of 
participants to treatment groups was necessary to facilitate recruitment in the research 
setting of Taiwan where there is high work demands and minimal support for sick 
leave. The typical workforce in cultures such as Taiwan face considerable issues 
when seeking therapy, as people rarely take sick leave and are encouraged not to, for 
fear of job loss and reduced pay. Although a conventional RCT would have provided 
stronger internal validity, a pragmatic RCT reflects the ‘real world’ scenario which 
provides good external validity.53 Hence a pragmatic RCT approach was adopted to 
allow more participants to be included in the study with less attrition. Future studies 
would also benefit from the use of standardised self-rating questionnaires to further 
monitor participants’ perception of the possible changes in quality of life and 
satisfaction with voice therapy. Furthermore, long-term follow-up of both treatments 
should occur to determine whether or not there is continuous improvement or 




In conclusion, the positive improvements in perceptual, physiological, and acoustic 
parameters of voice identified in this study provide evidence that intensive voice 
treatment is equally as beneficial in treating vocal nodules as a traditional voice 
therapy model. Intensive voice therapy should be considered as an option when 
providing clinical management to individuals with vocal nodules. Consequently this 
population would be able to regain better vocal communication and return to the 
workforce in a condensed period of time. This research warrants further investigation 
of the effects of intensive voice treatment on the long-term follow-up and participant 
perception of the benefits of this treatment protocol. Such research will ultimately 
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Table 1. Demographic Information of Participants 
Demographic variables TVT Group IVT Group P 
Total number of   
   participants 
29 24  
Mean age 37.52 37.54 0.871 
Severity of dysphonia     0.063 
   Mild 2 -  
   Mild-moderate 19 12  
   Moderate 7 12  
   Moderate-severe 1 -  
Occupations   0.817 
   Professional voice user 16 14  
   Non-professional voice  
     user 
13 10 
 




Table 2. Results of the One Sample t Tests for the Perceptual Parameters Over Time for the TVT and IVT Groups 
  TVT IVT 
Time Parameter Mean difference t p Mean difference t p 
Baseline to post-VH Grade 0.310 1.877 0.071 0.042 0.196 0.846 
 Roughness 0.241 1.425 0.241 0.125 0.681 0.503 
 Breathiness 0.138 1.162 0.255 0.042 0.296 0.770 
 Asthenia 0.103 1.140 0.264 0.208 1.735 0.096 
 Strain 0.276 2.512 0.018* 0.250 1.543 0.137 
Post-VH to post-tx Grade 0.552 3.266 0.003* 0.625 3.498 0.002* 
 Roughness 0.517 2.824 0.009* 0.625 3.498 0.002* 
 Breathiness 0.241 1.885 0.070 0.292 2.290 0.032* 
 Asthenia 0.241 1.885 0.070 0.292 2.598 0.016* 
 Strain 0.241 2.045 0.050* 0.292 2.598 0.016* 
Baseline to post-tx Grade 0.897 5.363 <0.001* 0.875 4.764 <0.001* 
 Roughness 0.828 5.255 <0.001* 0.750 3.892 0.001* 
 Breathiness 0.345 2.415 0.023* 0.458 2.696 0.013* 
 Asthenia 0.483 3.524 0.001* 0.458 3.114 0.005* 
 Strain 0.586 4.308 <0.001* 0.542 2.716 0.012* 
Abbreviations: IVT, intensive voice therapy; TVT, traditional voice therapy; VH, vocal hygiene; tx, treatment. 
* Statistically significant difference. 
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Table 3. Analysis of the Proportion of Change in Perceptual Ratings at Each Time Point Observed Between the Two Groups 
Parameter/Time  TVT, n (%) IVT, n (%) 
χ2 
P 
Grade       
 Baseline to post-VH Post-VH better 11 (38) 6 (25) 3.086 0.544 
 Post-VH worse 5 (17) 7 (29)   
 No change 13 (45) 11 (46)   
 Post-VH to post-tx Post-tx better 18 (62) 13 (54) 2.240 0.326 
 Post-tx worse 5 (17) 2 (8)   
 No change 6 (21) 9 (38)   
Baseline to post-tx Post-tx better 24 (83) 17 (71) 4.592 0.204 
 Post-tx worse 4 (14) 2 (8)   
 No change 1 (3) 5 (21)   
Roughness      
 Baseline to post-VH Post-VH better 10 (34) 5 (21) 2.613 0.241 
 Post-VH worse 6 (21) 8 (33)   
 No change 13 (45) 11 (46)   
 Post-VH to post-tx Post-tx better 18 (62) 13 (54) 2.240 0.326 
 Post-tx worse 5 (17) 2 (8)   
 No change 6 (21) 9 (38)   
 Baseline to post-tx Post-tx better 22 (76) 17 (71) 2.304 0.680 
 Post-tx worse 3 (10) 2 (8)   





     
 Baseline to post-VH Post-VH better 6 (21) 5 (20) 2.192 0.700 
 Post-VH worse 3 (10) 3 (13)   
 No change 20 (69) 16 (67)   
 Post-VH to post-tx Post-tx better 9 (31) 7 (29) 0.816 0.665 
 Post-tx worse 3 (10) 1 (4)   
 No change 17 (59) 16 (67)   
 Baseline to post-tx Post-tx better 11 (38) 10 (42) 0.516 0.915 
 Post-tx worse 3 (10) 2 (8)   
 No change 15 (52) 12 (50)   
Asthenia      
 Baseline to post-VH Post-VH better 5 (17) 3 (12) 2.274 0.518 
 Post-VH worse 2 (7) 0 (0)   
 No change 22 (76) 21 (88)   
 Post-VH to post-tx Post-tx better 9 (31) 6 (25) 3.185 0.203 
 Post-tx worse 3 (10) 0 (0)   
 No change 17 (59) 18 (75)   
 Baseline to post-tx Post-tx better 14 (48) 8 (33) 4.965 0.174 
 Post-tx worse 2 (7) 0 (0)   
 No change 13 (45) 16 (67)   
 
 




Strain      
 Baseline to post-VH Post-VH better 8 (28) 7 (29) 2.274 0.518 
 Post-VH worse 1 (3) 3 (13)   
 No change 20 (69) 14 (58)   
 Post-VH to post-tx Post-tx better 10 (35) 6 (25) 3.679 0.159 
 Post-tx worse 3 (10) 0 (0)   
 No change 16 (55) 18 (75)   
 Baseline to post-tx Post-tx better 17 (59) 11 (46) 4.915 0.178 
 Post-tx worse 2 (7) 2 (12)   
 No change 10 (34) 10 (42)   
Abbreviations: IVT, intensive voice therapy; TVT, traditional voice therapy; VH, vocal hygiene; tx, treatment. 
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Table 4. Within Group Analysis of Physiological Parameters for Both TVT and IVT Groups 
Parameter/Group Pre-VH mean (SD)          Post-VH mean (SD) Post-tx mean (SD) χ2 P 
Symmetry      
 TVT 1.22 (0.506) 1.26 (0.447) 1.26 (0.447) 0.182 0.913 
 IVT 1.28 (0.689) 1.17 (0.650) 1.04 (0.475) 1.200 0.549 
Amplitude      
 TVT 1.07 (0.550) 0.89 (0.698) 1.00 (0.679) 2.150 0.341 
 IVT 1.09 (0.733) 1.17 (0.576) 1.13 (0.694) 0.545 0.761 
Mucosal wave      
 TVT 2.00 (0.480) 1.48 (0.802) 0.63 (0.688) 32.689 <0.001* 
 IVT 1.83 (0.717) 1.22 (0.671) 0.39 (0.583) 32.747 <0.001* 
VF edge smoothness      
 TVT 1.81 (0.483) 1.41 (0.501) 0.96 (0.437) 31.524 <0.001* 
 IVT 1.74 (0.541) 1.30 (0.470) 1.13 (0.548) 16.423 <0.001* 
Regularity      
TVT 1.37 (0.492) 1.30 (0.454) 1.00 (0.555) 8.909 0.012* 
IVT 1.35 (0.573) 1.13 (0.548) 0.96 (0.475) 8.400 0.015* 
Glottal closure      
TVT 1.52 (0.509) 1.15 (0.602) 0.63 (0.565) 27.800 <0.001* 
IVT 1.65 (0.573) 1.26 (0.619) 1.09 (0.596) 10.793 0.005* 
Abbreviations: IVT, intensive voice therapy; TVT, traditional voice therapy; VH, vocal hygiene; tx, treatment; VF, vocal fold; SD, standard 
deviation. * Statistically significant difference. 
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Table 5. Between Group Analysis of Extent of Change in Physiological Parameters in Both the TVT and IVT Groups 
Time /Parameter TVT  
Mean difference (SD) 
IVT  
Mean difference (SD) 
Z P 
Pre-VH versus post-VH     
  Symmetry -0.04 (0.518) 0.08 (0.584) -0.789 0.430 
  Amplitude 0.19 (0.622) -0.08 (0.584) -1.486 0.137 
  Mucosal wave 0.52 (0.849) 0.63 (0.647) -0.536 0.592 
  VF edge smoothness 0.41 (0.501) 0.42 (0.584) -0.185 0.853 
  Regularity 0.07 (0.550) 0.21 (0.558) -0.863 0.388 
  Glottal closure 0.37 (0.688) 0.38 (0.875) -0.061 0.951 
Pre-tx versus post-tx     
  Symmetry -0.07 (0.456) 0.22 (0.795) -1.375 0.169 
  Amplitude 0.07 (0.651) -0.04 (0.562) -0.667 0.505 
  Mucosal wave 1.38 (0.775) 1.43 (0.788) -0.300 0.976 
  VF edge smoothness 0.83 (0.602) 0.61 (0.656) -1.121 0.262 
  Regularity 0.38 (0.728) 0.39 (0.656) -0.114 0.909 
  Glottal closure 0.86 (0.693) 0.57 (0.728) -1.458 0.145 
Post-VH versus post-tx     
  Symmetry 0.00 (0.602) 0.13 (0.757) -0.371 0.711 
  Amplitude -0.11 (0.506) 0.04 (0.562) -1.013 0.311 
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  Mucosal wave 0.85 (0.864) 0.83 (0.778) 0.020 0.841 
  VF edge smoothness 0.44 (0.506) 0.17 (0.576) -1.632 0.103 
  Regularity 0.30 (0.542) 0.17 (0.576) -1.080 0.280 
  Glottal closure 0.52 (0.580) 0.17 (0.778) -1.757 0.079 




















Table 6. Physiological Paired Comparison Ratings 
Parameter/Time  TVT, n (%) IVT, n (%) 
χ2 
P 
Vocal nodule size      
 Baseline to post-VH Post-VH smaller 13 (48) 14 (58) 0.752 0.687 
 Post-VH larger 4 (15) 2 (8)   
 No change 10 (37) 8 (33)   
 Post-VH to post-tx Post-tx smaller 19 (68) 13 (57) 1.122 0.571 
 Post-tx larger 4 (14) 3 (13)   
 No change 5 (18) 7 (30)   
 Baseline to post-tx Post-tx smaller 20 (69) 21 (91) 4.680 0.096 
 Post-tx larger 4 (14) 0 (0)   
 No change 5 (17) 2 (9)   
Surrounding oedema      
 Baseline to post-VH Post-VH smaller 14 (52) 13 (54) 1.719 0.423 
 Post-VH larger 4 (15) 1 (4 )   
 No change 9 (33) 10 (42)   
 Post-VH to post-tx Post-tx smaller 20 (71) 16 (69) 0.156 0.925 
 Post-tx larger 3 (11) 2 (9)   
 No change 5 (18) 5 (22)   
 Baseline to post-tx Post-tx smaller 22 (76) 19 (83) 5.264 0.072 
 Post-tx larger 5 (17) 0 (0)   
 No change 2 (7) 4 (17)   
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Abbreviations: VH, vocal hygiene; tx, treatment; IVT, intensive voice therapy; TVT, traditional voice therapy. 
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Table 7. Results – MPT, MFR, and Subglottic Pressure for TVT and IVT Groups 
Interaction Effect Main Effect Between Group Effect  
Task/Group 
 
Pre-VH             
Mean (SD)          
 
Post-VH               
Mean (SD) 
 
Post-tx             















MPT (s)             
 TVT 8.53 (3.59) 8.81 (3.14) 9.57 (3.64) 0.972 0.385 0.037 0.227 0.798 0.009 0.001 0.974 <0.005 
 IVT 9.04 (4.35) 9.07 (3.24) 8.72 (2.79)          
             
MFR (mL/s)             
 TVT 139.60 (60.65) 143.65 (71.00) 140.34 (65.02) 0.634 0.530 0.005 0.165 0.848 0.007 0.959 0.332 0.018 
 IVT 163.35 (65.07) 150.68 (75.52) 159.09 (81.21)          
             
Subglottic pressure 
(cmH2O) 
            
 TVT 10.10 (3.08) 9.64 (2.92) 10.68 (3.04) 1.886 0.162 0.070 0.762 0.472 0.030 2.478 0.122 0.046 
 IVT 11.32 (2.80) 11.41 (3.09) 11.18 (3.37)  
 
        
Abbreviations: VH, vocal hygiene; tx, treatment; MPT, maximum phonation time; MFR, mean airflow rate; IVT, intensive voice therapy; TVT, traditional voice therapy; SD, 
standard deviation.  
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Table 8. Results – F0, jitter, shimmer, NHR, VI of Prolonged Vowel /a/ and VI of Conversational Speech Sample for TVT and IVT Groups 
Interaction Effect Main Effect for Time Between Group Effect  
Task/Group 
 
Pre-VH             
Mean (SD)          
 
Post-VH               
Mean (SD) 
 
Post-tx             















F0 (Hz)             
 TVT 205.75 (29.28) 205.03 (27.27) 233.92 (29.56) 0.637 0.533 0.025 60.303 <0.001* 0.707 0.342 0.561 0.007 
 IVT 197.88 (33.56) 203.79 (23.89) 230.67 (25.65)          
             
Jitter (%)             
 TVT 2.03 (1.18) 1.65 (0.96) 1.20 (0.92) 0.515 0.600 0.020 18.537 <0.001* 0.426 0.275 0.602 0.005 
 IVT 2.08 (1.06) 1.92 (0.89) 1.21 (0.84)          
             
Shimmer (%)             
 TVT 5.17 (1.90) 4.59 (1.82) 3.87 (2.10) 0.495 0.613 0.019 10.231 <0.001* 0.290 1.158 0.287 0.022 
 IVT 5.83 (2.43) 5.24 (2.21) 3.96 (1.83)  
 






NHR             
 TVT 0.16 (0.04) 0.15 (0.03) 0.14 (0.05) 0.089 0.915 0.004 3.508 0.038* 0.123 0.046 0.831 0.001 
 IVT 0.16 (0.04) 0.15 (0.03) 0.14 (0.04)          
             
VI of prolonged     
/a/  
(dB) 
            
 TVT 75.73 (5.53) 76.43 (5.34) 79.92 (6.51) 0.196 0.823 0.008 9.931 <0.001* 0.293 0.541 0.465 0.011 
 IVT 75.28 (5.79) 75.15 (4.33) 78.70 (6.97)          
             
VI of conversation 
(dB) 
            
 TVT 71.50 (3.81) 71.85 (2.75) 72.27 (3.79) 1.184 0.315 0.047 1.122 0.334 0.045 0.097 0.757 0.002 
 IVT 72.19 (3.52) 70.84 (3.11) 71.91 (3.99)          
             
Abbreviations: F0, fundamental frequency; NHR, noise-to-harmonic ratio; VI, vocal intensity; IVT, intensive voice therapy; TVT, traditional voice therapy; SD, standard 
deviation. 
* Statistically significant difference.  
 
 
 
